Abstract

<b>227</b> <h3><b>Objectives</b></h3> Mesenchymal stem cells (MSCs) have shown promise as treatment for graft-versus-host disease (GvHD) following allogeneic bone marrow transplantation (alloBMT). Mechanisms mediating <i>in vivo</i> effects of MCSs remain largely...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call